CTRP8‐RXFP1 is emerging as a new ligand–receptor system which promotes GBM migration (Glogowska et al., 2013) and, as shown here, protects against the cytotoxic effects of the DNA alkylating drug TMZ. Here, C1QTNF8 is linked to glioblastoma.